Placenta previa and vasa previa: Clinical sciences

1,010views

00:00 / 00:00

Decision-Making Tree

Preguntas

Preguntas del estilo USMLE Step 2

de completadas

A 36-year-old woman, gravida 5, para 4, at 32 weeks of gestation presents to labor and delivery triage with vaginal spotting that began 1 hour ago. She has no contractions, no loss of fluid, and normal fetal movement. Her pregnancy is complicated by placenta previa diagnosed at 20 weeks on an anatomy ultrasound. Her medical history is notable for two uncomplicated vaginal deliveries, one prior C-section for breech presentation, and a vaginal birth after cesarean (VBAC). Temperature is 36.9°C (98.4°F), pulse is 82/min, respirations are 18/min, and blood pressure is 116/74 mmHg. A sterile speculum exam (SSE) shows a small amount of blood in the vaginal vault but no active bleeding and the cervix appears parous and closed. A non-stress test (NST) shows a reactive and reassuring fetal heart rate pattern with a baseline in the 140s and moderate variability. There are no decelerations, and a single small uterine contraction is noted that the patient did not feel. Which of the following is the most appropriate next step in management? 

Transcript

Watch video only

Placenta previa is when placental tissue partially or completely covers the internal cervical os. When the placental edge is within 20 millimeters of the internal cervical os but isn’t actually covering it, it’s called a low-lying placenta. In contrast, in vasa previa, the fetal vessels either cross the internal os or are within 20 millimeters of it. The etiologies are unknown, though each condition has independent risk factors. These entities are important because they can cause bleeding, especially in labor or when membranes rupture. In placenta previa, the source of bleeding is maternal, whereas bleeding in vasa previa comes from the fetus.

Your first step in evaluating a patient presenting with a chief concern suggesting placenta previa or vasa previa is to do a CABCDE assessment to determine if they unstable. Unstable patients may have heavy vaginal bleeding, so prepare for urgent surgical management. Stabilize the airway, breathing, and circulation, and intubate the patient if necessary. Obtain IV access, and continuously monitor their vital signs. Initiate continuous fetal heart rate monitoring, and check for any signs of labor. Perform a sterile speculum exam to assess the volume of bleeding and check visually if the cervix is dilated.

Keep in mind that you should never perform a digital cervical exam on a patient with placenta previa or vasa previa, as it can disrupt the placenta and vessels and worsen the situation.

After the primary assessment, obtain a focused history, physical exam, and labs including CBC, PT, INR, PTT, fibrinogen, and a type and crossmatch. You may also need to perform an ultrasound to help with diagnosis, but don’t delay treatment while waiting for imaging.

Let’s talk about the history of those with placenta previa. Your patient may report dizziness, tunnel vision, and anxiety due to the acute blood loss, which occurs when shearing forces from uterine contractions and cervical changes disrupt the placental attachment site. There could also be a known abnormal placental location from an earlier ultrasound.

There are conditions that raise the risk of placenta previa, such as high parity, history of a prior c-section or other uterine surgery, advanced maternal age, multiple gestations, smoking, and in vitro fertilization.

A physical exam might reveal hypotension, tachycardia, and altered mental status. They may appear pale, and their skin might feel cold or clammy. Typically, there will be painless vaginal bleeding, which could spontaneously resolve or it might be ongoing. With severe bleeding, you may find fetal bradycardia as well.

Fuentes

  1. "Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of bleeding in the late preterm period" Am J Obstet Gynecol (2018)
  2. "#37: Diagnosis and management of vasa previa" Am J Obstet Gynecol (2015)
  3. "Guideline No. 402: Diagnosis and Management of Placenta Previa" J Obstet Gynaecol Can (2020)
Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX